Released on: December 4, 2007, 1:47 pm

Press Release Author: AnaSpec Inc.

Industry: Biotech

Press Release Summary: AnaSpec introduced a collection of peptides related to the
family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or
cell cycle research.

Press Release Body: December 4, 2007 - San Jose, CA
This month AnaSpec introduced a collection of peptides related to the family of
proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle
research. These important regulators of apoptosis have been implicated in a number
of neoplasms, including melanoma, breast, prostate, and lung carcinomas, as well as
schizophrenia and autoimmunity.
The Bcl-2 family is comprised of more than 20 members, divided into 3 subfamilies.
Depending on Bcl-2 subcellular localization, it can inhibit (anti-apoptotic members)
or induce (pro-apoptotic members) apoptosis.
Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents (dyes, assay kits, & antibodies), and
combinatorial chemistry.
For more information, visit www.anaspec.com


Web Site: http://www.anaspec.com

Contact Details: 2149 O\'Toole Ave.
San Jose, CA 95131
ping@anaspec.com